Cargando…
Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies
BACKGROUND: Androgen signalling remains the seminal therapeutic approach for the management of advanced prostate cancer. However, most tumours eventually shift towards an aggressive phenotype, characterised by androgen independence and treatment resistance. The cyclic adenosine monophosphate (cAMP)...
Autores principales: | Gulliver, Chloe, Huss, Sebastian, Semjonow, Axel, Baillie, George S., Hoffmann, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628190/ https://www.ncbi.nlm.nih.gov/pubmed/37740039 http://dx.doi.org/10.1038/s41416-023-02417-5 |
Ejemplares similares
-
The CAPRA&PDE4D5/7/9 Prognostic Model Is Significantly Associated with Adverse Post-Surgical Pathology Outcomes
por: Gulliver, Chloe, et al.
Publicado: (2022) -
Reduced PDE4D7 in prostate cancer correlates with genomic downregulation within the upstream PDE4D coding region
por: Gulliver, Chloe, et al.
Publicado: (2023) -
The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion Status
por: van Strijp, Dianne, et al.
Publicado: (2019) -
The Prognostic PDE4D7 Score in a Diagnostic Biopsy Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes
por: van Strijp, Dianne, et al.
Publicado: (2018) -
The enigmatic helicase DHX9 and its association with the hallmarks of cancer
por: Gulliver, Chloe, et al.
Publicado: (2020)